This document is an excerpt from the EUR-Lex website
Document 52006XC1124(02)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.10.2006 to 31.10.2006 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.10.2006 to 31.10.2006 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.10.2006 to 31.10.2006 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
OJ C 287, 24.11.2006, p. 7–11
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
24.11.2006 |
EN |
Official Journal of the European Union |
C 287/7 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.10.2006 to 31.10.2006
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))
(2006/C 287/03)
— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||||
4.10.2006 |
Abilify |
|
EU/1/04/276/036 |
6.10.2006 |
|||||||
4.10.2006 |
Abilify |
|
EU/1/04/276/036 |
6.10.2006 |
|||||||
6.10.2006 |
Travatan |
|
EU/1/01/199/001-002 |
10.10.2006 |
|||||||
11.10.2006 |
Invirase |
|
EU/1/96/026/001-002 |
13.10.2006 |
|||||||
17.10.2006 |
Cetrotide |
|
EU/1/99/100/001-003 |
19.10.2006 |
|||||||
19.10.2006 |
Zometa |
|
EU/1/01/176/001-006 |
23.10.2006 |
|||||||
19.10.2006 |
Zevalin |
|
EU/1/03/264/001 |
23.10.2006 |
|||||||
20.10.2006 |
Herceptin |
|
EU/1/00/145/001 |
24.10.2006 |
|||||||
20.10.2006 |
PritorPlus |
|
EU/1/02/215/001-012 |
24.10.2006 |
|||||||
20.10.2006 |
Enbrel |
|
EU/1/99/126/001-018 |
24.10.2006 |
|||||||
20.10.2006 |
Caelyx |
|
EU/1/96/011/001-004 |
24.10.2006 |
|||||||
20.10.2006 |
Avonex |
|
EU/1/97/033/001-003 |
24.10.2006 |
|||||||
20.10.2006 |
Faslodex |
|
EU/1/03/269/001 |
24.10.2006 |
|||||||
20.10.2006 |
ViraferonPeg |
|
EU/1/00/132/001-050 |
24.10.2006 |
|||||||
23.10.2006 |
Taxotere |
Aventis Pharma S.A., 20 Avenue Raymond Aron, Antony Cedex 92165, France |
EU/1/95/002/001-002 |
25.10.2006 |
|||||||
23.10.2006 |
PhotoBarr |
|
EU/1/04/272/001-002 |
25.10.2006 |
|||||||
23.10.2006 |
Dynepo |
|
EU/1/02/211/001-005 |
26.10.2006 |
|||||||
24.10.2006 |
PegIntron |
|
EU/1/00/131/001-050 |
25.10.2006 |
|||||||
24.10.2006 |
AVANDIA |
|
EU/1/00/137/002-018 |
26.10.2006 |
|||||||
24.10.2006 |
Aclasta |
|
EU/1/05/308/001-002 |
26.10.2006 |
|||||||
24.10.2006 |
Prometax |
|
EU/1/98/092/001-018 |
26.10.2006 |
|||||||
24.10.2006 |
Invanz |
|
EU/1/02/216/001-002 |
26.10.2006 |
|||||||
24.10.2006 |
Apidra |
|
EU/1/04/285/013-020 |
26.10.2006 |
|||||||
24.10.2006 |
Fuzeon |
|
EU/1/03/252/001-003 |
26.10.2006 |
|||||||
24.10.2006 |
Avandamet |
|
EU/1/03/258/001-022 |
26.10.2006 |
|||||||
26.10.2006 |
Ketek |
|
EU/1/01/191/001-005 |
30.10.2006 |
|||||||
26.10.2006 |
Levviax |
|
EU/1/01/192/001-005 |
30.10.2006 |
|||||||
26.10.2006 |
Actos |
|
EU/1/00/150/001-024 |
30.10.2006 |
|||||||
26.10.2006 |
Glustin |
|
EU/1/00/151/001-022 |
30.10.2006 |
|||||||
26.10.2006 |
Sustiva |
|
EU/1/99/110/001-009 |
30.10.2006 |
|||||||
26.10.2006 |
Stocrin |
|
EU/1/99/111/001-009 |
30.10.2006 |
|||||||
26.10.2006 |
Exelon |
|
EU/1/98/066/001-018 |
30.10.2006 |
|||||||
26.10.2006 |
Helixate NexGen |
|
EU/1/00/144/001-003 |
30.10.2006 |
|||||||
26.10.2006 |
Vfend |
|
EU/1/02/212/001-026 |
30.10.2006 |
|||||||
27.10.2006 |
Pritor |
|
EU/1/98/089/001-019 |
31.10.2006 |
|||||||
27.10.2006 |
Ariclaim |
|
EU/1/04/283/001-007 |
31.10.2006 |
|||||||
27.10.2006 |
Rebetol |
|
EU/1/99/107/001-005 |
31.10.2006 |
|||||||
27.10.2006 |
Remicade |
|
EU/1/99/116/001-003 |
31.10.2006 |
|||||||
27.10.2006 |
Avaglim |
|
EU/1/06/349/001-008 |
31.10.2006 |
|||||||
27.10.2006 |
Viramune |
|
EU/1/97/055/001-003 |
31.10.2006 |
|||||||
27.10.2006 |
Invirase |
|
EU/1/96/026/001-002 |
31.10.2006 |
|||||||
27.10.2006 |
Tracleer |
|
EU/1/02/220/001-005 |
31.10.2006 |
|||||||
30.10.2006 |
FOSAVANCE |
|
EU/1/05/310/001-005 |
1.11.2006 |
|||||||
30.10.2006 |
Lyrica |
|
EU/1/04/279/001-035 |
1.11.2006 |
|||||||
30.10.2006 |
NutropinAq |
|
EU/1/00/164/003-005 |
1.11.2006 |
|||||||
30.10.2006 |
Keppra |
|
EU/1/00/146/001-030 |
3.11.2006 |
|||||||
30.10.2006 |
Noxafil |
|
EU/1/05/320/001 |
2.11.2006 |
|||||||
30.10.2006 |
Posaconazole SP |
|
EU/1/05/321/001 |
2.11.2006 |
|||||||
30.10.2006 |
Nespo |
|
EU/1/01/184/001-068 |
2.11.2006 |
|||||||
30.10.2006 |
Aranesp |
|
EU/1/01/185/001-068 |
1.11.2006 |
|||||||
31.10.2006 |
Lantus |
|
EU/1/00/134/001-037 |
14.11.2006 |
|||||||
31.10.2006 |
Insuman |
|
EU/1/97/030/065-084 |
6.11.2006 |
|||||||
31.10.2006 |
Optruma |
|
EU/1/98/074/001-004 |
6.11.2006 |
|||||||
31.10.2006 |
Evista |
|
EU/1/98/073/001-004 |
6.11.2006 |
|||||||
31.10.2006 |
Telzir |
|
EU/1/04/282/001-002 |
7.11.2006 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
The European Medicines Agency |
7, Westferry Circus, Canary Wharf |
London E14 4HB |
United Kingdom |
(1) OJ L 136 of 30 April 2004, page 1